...
机译:预测高级浆液癌临床结果的2蛋白签名
Shandong Univ Qilu Hosp Dept Obstet &
Gynecol 107 Wenhua Xi Rd Jinan 250012 Shandong Peoples;
Zoucheng Peoples Hosp Dept Gynecol Zoucheng Shandong Peoples R China;
Shandong Univ Qilu Hosp Dept Obstet &
Gynecol 107 Wenhua Xi Rd Jinan 250012 Shandong Peoples;
Shandong Univ Qilu Hosp Dept Obstet &
Gynecol 107 Wenhua Xi Rd Jinan 250012 Shandong Peoples;
Zhenjiang First Peoples Hosp Dept Obstet &
Gynecol Zhenjiang Jiangsu Peoples R China;
Zhejiang Prov Ctr Dis Control &
Prevent Hangzhou Zhejiang Peoples R China;
Shandong Univ Qilu Hosp Dept Obstet &
Gynecol 107 Wenhua Xi Rd Jinan 250012 Shandong Peoples;
Shandong Univ Qilu Hosp Dept Obstet &
Gynecol 107 Wenhua Xi Rd Jinan 250012 Shandong Peoples;
Shandong Univ Inst Diagnost Sch Med 44 Wenhua Xi Rd Jinan 250012 Shandong Peoples R China;
Shandong Univ Qilu Hosp Dept Obstet &
Gynecol 107 Wenhua Xi Rd Jinan 250012 Shandong Peoples;
CXCL11; HMGA2; MUC16; HGSOC; Clinical outcome;
机译:预测高级浆液癌临床结果的2蛋白签名
机译:高级浆液癌中的基因组重排签名及临床结果
机译:Cox-rasso分析显示了10-lncrNA签名,以预测高级浆液癌癌症的患者的结果
机译:环境电离质谱成像的浆液卵巢癌侵蚀性和手术结果的分子标记
机译:溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
机译:高级别浆液性卵巢癌的基因组重排特征和临床结果
机译:基于糖蛋白质的肿瘤亚型签名和高级浆液癌的临床结果预测